Form 4: Intuitive Surgical Exec Sells Shares After Option Exercise

Intuitive Surgical's EVP & Chief Commercial and Marketing Officer, Henry L. Charlton, executed a series of option exercises and subsequent stock sales totaling 13,731 shares under a Rule 10b5-1 plan.

Summary

• Henry L. Charlton, EVP & Chief Commercial and Marketing Officer of Intuitive Surgical Inc. (ISRG), reported multiple transactions on November 12, 2025.
• Mr. Charlton exercised non-qualified stock options to acquire a total of 9,000 shares of common stock.
• These exercises occurred at prices ranging from $177.9867 to $347.4167 per share.
• Concurrently, Mr. Charlton sold a total of 13,731 shares of common stock at a uniform price of $580 per share.
• The total shares sold include the 9,000 shares acquired through option exercises and an additional 4,731 shares from his existing holdings.
• All transactions were conducted under a Rule 10b5-1 trading plan, which is set to expire on June 1, 2026.
• Following these transactions, Mr. Charlton's direct beneficial ownership of Intuitive Surgical common stock decreased from an initial 7,787 shares to 3,056 shares.
• He retains 1,929 non-qualified stock options with an exercise price of $347.4167 and an expiration date of August 26, 2031.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a routine disclosure of insider transactions executed under a pre-arranged 10b5-1 plan, which typically does not reflect new sentiment about the company's prospects.

Positives

• The executive realized significant gains by exercising options at lower prices and selling shares at a higher market price of $580 per share.
• Transactions were conducted under a pre-arranged Rule 10b5-1 plan, indicating planned and compliant insider trading.

Negatives

• The reporting person's direct beneficial ownership of common stock decreased by 4,731 shares, from 7,787 to 3,056 shares, which could be interpreted as a reduction in direct exposure to the company's equity.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing details routine insider transactions under a pre-arranged trading plan, which is a common practice among executives in publicly traded companies across various industries. It does not provide specific insights into broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: The sale of shares by a key executive, even under a 10b5-1 plan, slightly reduces insider ownership, which some investors might monitor. However, the routine nature of these transactions typically has minimal impact.
• Employees, Customers, Suppliers, Creditors: No direct impact is indicated by this insider trading report.

Next Steps

• The Rule 10b5-1 trading plan under which these transactions occurred is scheduled to expire on June 1, 2026.

Key Dates

Keywords

Intuitive Surgical, ISRG, Form 4, Insider Trading, Stock Options, Executive Compensation, Stock Sale, 10b5-1 Plan